While BRCA1 pathogenic variants confer a more aggressive tumor phenotype, BRCA2 pathogenic variants typically resemble sporadic breast cancer.35 There is good agreement between our observed results regarding the tumor characteristic differences between BRCA1/2 and non‐BRCA breast cancer cases and what has been previously reported in literature. The gene discussed is BRCA2; the disease is breast cancer.